Project aimed to combine the power of genomics, post genomics, and proteomics in order to systematically develop diagnostics for preeclampsia and IUGR as a fundamental requirement for curing the pathologies, utilising placental biomarkers for early detection of PE and IUGR risk, using simple blood tests of pregnant women.

Partners includde: Diagnostic Technologies (Israel); Barking, Havering & Redbridge Hospitals NHS Trust, Foetal Medicine Foundation (UK); Medical University of Graz, (Austria); Semmelweis University Hospital (Hungary); ImunoSTAR (Portugal); University of Milan (Italy); University of Zurich (Switzerland); Wallac Oy (Finland).